Catalyst Wire Dossier Catalyst Wire Dossier

BioMime Sirolimus Eluting Coronary Stent

Sirolimus-eluting coronary stent · Meril Life Sciences Pvt. Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BioMime Sirolimus Eluting Coronary Stent, covering 2018-04-11 to 2018-04-11. Get the full timeline:

Most recent: Clinical Trial Update: An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study.

See pricing